Barchart.com
Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
Less than $10/month! Screen on your Watchlists and Portfolios with Barchart Plus. FREE 30 Day Trial
Menu
Stocks | Futures | Watchlist | News | More
 
or
Watchlist | Portfolio | Dashboard
Site News
Contact
Market:

Rhythm Pharmaceuticals Inc (RYTM)

Rhythm Pharmaceuticals Inc (RYTM)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
News & Headlines for [[ item.sessionDateDisplayLong ]]
Notes
Alerts
Watch
Help
Go To:
Rhythm Pharmaceuticals Announces Participation in Upcoming Investor Conferences GlobeNewswire - Wed Nov 6, 7:00AM CST

RYTM : 64.06 (-2.32%)
Rhythm Pharmaceuticals Reports Third Quarter 2024 Financial Results and Business Update GlobeNewswire - Tue Nov 5, 3:01PM CST

RYTM : 64.06 (-2.32%)
Rhythm Pharmaceuticals Announces Five New Data Presentations at ObesityWeek® 2024 GlobeNewswire - Mon Nov 4, 3:01PM CST

RYTM : 64.06 (-2.32%)
Rhythm Pharmaceuticals and Axovia Therapeutics Announce Joint Research Collaboration in Bardet-Biedl Syndrome GlobeNewswire - Thu Oct 24, 5:00AM CDT

RYTM : 64.06 (-2.32%)
Rhythm Pharmaceuticals to Report Third Quarter 2024 Financial Results on Tuesday, November 5, 2024 GlobeNewswire - Wed Oct 23, 7:00AM CDT

RYTM : 64.06 (-2.32%)
Rhythm Pharmaceuticals Announces New Employment Inducement Grants GlobeNewswire - Tue Oct 8, 3:01PM CDT

RYTM : 64.06 (-2.32%)
Melanocortin Receptor R&D to Target Increasing Prevalence of Obesity-Related Disorders FinancialNewsMedia - Thu Oct 19, 2023

EQNX::TICKER_START (NYSE:PTN),(NASDAQ:RYTM),(NASDAQ:VKTX),(NASDAQ:GPCR),(NYSE:NVO) EQNX::TICKER_END

PTN : 1.2000 (unch)
RYTM : 64.06 (-2.32%)
VKTX : 60.60 (-3.76%)
GPCR : 36.97 (-4.47%)
NVO : 107.06 (-1.86%)
Melanocortin Receptor R&D to Target Increasing Prevalence of Obesity-Related Disorders PR Newswire - Thu Oct 19, 2023

/PRNewswire/ -- The Melanocortin Receptor 4 (MC4R) is a protein-coupled receptor primarily expressed in the central nervous system, playing a pivotal role in...

PTN : 1.2000 (unch)
RYTM : 64.06 (-2.32%)
VKTX : 60.60 (-3.76%)
GPCR : 36.97 (-4.47%)
NVO : 107.06 (-1.86%)
What Will Amgen Buy Next? Motley Fool - Thu Jun 29, 2023

The biotech could pursue these two budget-friendly targets.

REGN : 821.00 (-0.57%)
AMGN : 298.84 (-7.14%)
HZNP : 116.30 (+0.04%)
NTLA : 16.65 (-4.86%)
RYTM : 64.06 (-2.32%)
3 Breakout Growth Stocks to Buy for the Long Haul Motley Fool - Mon Jan 9, 2023

These three have had big-time share gains backed up by breakthrough science.

BLTE : 81.15 (+3.19%)
TMDX : 91.41 (+2.58%)
RYTM : 64.06 (-2.32%)

Barchart Exclusives

1 Dividend Aristocrat to Bet on Trump's Tariffs and the Fed's Rate Cuts Barchart - 15 minutes ago
Nucor is one stock that stands to benefit from the Fed's rate cuts as well as any possible tariffs under a Trump administration. It is also a dividend aristocrat, and has increased its payouts for over 5 decades. Read more
Want to use this as
your default charts setting?
Save this setup as a Chart Templates
Switch the Market flag
for targeted data from your country of choice.
Open the menu and switch the
Market flag for targeted data from your country of choice.
Want Streaming Chart Updates?
Switch your Site Preferences
to use Interactive Charts
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.
Use your up/down arrows to move through the symbols.

Free Barchart Webinar

[[ data.userDate ]]
[[ data.eventTime | date: 'EEE, MMM dd, yyyy h:mm a' ]] [[ zone ]]
Reserve Your Spot